Regeneron Pharmaceuticals said earlier this month that it will acquire “substantially all” of 23andMe’s assets for $256 million.
Related Posts
Apple’s inaccurate AI news alerts shows the tech has a growing misinformation problem
An artificial intelligence feature on iPhones is generating fake news alerts, stoking concerns about the technology’s ability to spread misinformation.
DraftKings: A $21 Billion SPAC Betting It Can Hide Its Black Market Operations
- andrewkewnzy@gmail.com
- January 17, 2021
- 0
Initial Disclosure: After extensive research, we have taken a short position in shares of DraftKings, Inc. This report represents our opinion, and we encourage every […]
Transport stock charts aren’t saying the economy is fine
The Dow Jones Transportation Average is headed for a losing week and has fallen back below its pre-April 2 Liberation Day levels.